ARUP Consult released new and updated resources on genetic cardiovascular disease, the effects of common anticoagulants on coagulation testing, laboratory testing for primary sclerosing cholangitis.
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.
To assist clinicians in providing the best possible care for patients with thyroid disease, ARUP Laboratories has released a comprehensive new thyroid disease testing resource on ARUP Consult.
A recording of an hour-long webinar updating the status of diagnostic testing for SARS-CoV-2 nearly a year after the first tests were introduced is now available to watch for free.
In December 2020, Utah’s Newborn Screening Program identified the first patient with guanidinoacetate methyltransferase (GAMT) deficiency solely through newborn screening.
Andrew Fletcher, MD, MBA, CPE, CHCQM, FCAP, medical director of Consultative Services at ARUP, has coauthored a study that shows clinicians frequently do not adhere to clinical guidelines.
ARUP Laboratories now offers testing to detect the virus that causes COVID-19 using saliva specimens. The molecular diagnostic test is available with preapproval to ARUP clients nationwide.
Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study.
ARUP and Techcyte, a leading developer of artificial intelligence (AI)-based image analysis solutions, published a study on their groundbreaking AI-augmented ova and parasite detection tool.
Utahns tested for COVID-19 at the U Redwood Health Center are being asked to volunteer for a study to evaluate whether saliva and other specimen types can be effectively used to test for the disease.